-
ACCELERATING HEALTH ECONOMIC MODEL CONCEPTUALIZATION USING MULTI-AGENTIC GENERATIVE AI SYSTEMS
Mar 18, 2026, 21:38 PM -
CURATING FIT-FOR-PURPOSE GEOGRAPHIC REAL-WORLD DATA
Mar 18, 2026, 21:38 PM -
IMPACT OF TIME-VARYING RELAPSE RISK ON LONG-TERM COST-EFFECTIVENESS OUTCOMES IN CHRONIC RELAPSING DISEASES
Mar 18, 2026, 21:38 PM -
EXTERNAL CONTROL ARM FEASIBILITY ACROSS EXTERNAL DATA SOURCES IN ONCOLOGY: METHODOLOGICAL AND REGULATORY SCIENCE CONSIDERATIONS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF A NOVEL THERAPY TO PREVENT ADVANCED FRAILTY AMONG PEOPLE WITH HIV
Mar 18, 2026, 21:38 PM -
PREDICTORS OF 30-DAY HOSPITAL READMISSION AMONG PATIENTS WITH OPIOID USE DISORDER
Mar 18, 2026, 21:38 PM -
DEVELOPING AND OPERATIONALIZING A SOCIETAL VALUE FRAMEWORK: A STYLIZED CASE STUDY IN ADVANCED HEPATOCELLULAR CARCINOMA
Mar 18, 2026, 21:38 PM -
COMPARING HEALTH CARE UTILIZATION AND EXPENDITURES BETWEEN VALUE-BASED PAYMENT AND NON-VALUE-BASED PAYMENT IN MEDICARE ADVANTAGE
Mar 18, 2026, 21:38 PM -
VALIDATION OF THE METASLR ROB MODULE: A MULTI-AGENT GENERATIVE AI SYSTEM FOR AUTOMATING COCHRANE RISK OF BIAS 2.0 ASSESSMENTS
Mar 18, 2026, 21:38 PM -
EVALUATING INITIAL MEDICATION ADHERENCE THRESHOLDS AS PREDICTORS OF CONTINUATION ADHERENCE AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A CLAIMS-BASED ANALYSIS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF INAVOLISIB IN THE TREATMENT OF PIK3A-MUTATED, HR+/HER2-ABC LOCALLY ADVANCED OR METASTATIC BREAST CANCER IN THE US
Mar 18, 2026, 21:38 PM -
PERFORMANCE OF TRANSPORTABILITY METHODS UNDER EFFECT MEASURE MODIFIER OMISSION: A PLASMODE SIMULATION STUDY IN LUNG CANCER SCREENING
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT OF INTRODUCING TAPINAROF, A NEW ARYL HYDROCARBON RECEPTOR AGONIST, FOR THE TREATMENT OF ATOPIC DERMATITIS IN ADULT AND PEDIATRIC PATIENTS, FROM A U.S. MEDICAID PLAN PERSPECTIVE
Mar 18, 2026, 21:38 PM -
GEOSPATIAL EQUITY AND ECONOMIC IMPLICATIONS OF HEALTH DEVELOPMENT OFFICES IN HUNGARY
Mar 18, 2026, 21:38 PM -
AN AUTOMATED FEASIBILITY ASSESSMENT TOOL FOR INDIRECT TREATMENT COMPARISONS ACROSS MULTIPLE ANALYTICAL METHODS
Mar 18, 2026, 21:38 PM -
CHARACTERIZATION OF PATIENT-REPORTED OUTCOME UTILIZATION AND RESULTS REPORTED IN BREAST CANCER CLINICAL TRIALS REGISTERED ON CLINICALTRIALS.GOV (2020-2024)
Mar 18, 2026, 21:38 PM -
THE SCALE OF PROLONGED UNCERTAINTY: ESTIMATING U.S. PATIENT POPULATIONS AFFECTED BY OVERDUE ACCELERATED APPROVAL CONFIRMATORY TRIALS
Mar 18, 2026, 21:38 PM -
LEVERAGING ARTIFICIAL INTELLIGENCE TO EXPEDITE DOSSIER DEVELOPMENT: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
COST OF ILLNESS AMONG ALZHEIMER’S DISEASE AND RELATED DEMENTIAS (ADRD) MEDICARE PATIENTS IN THE UNITED STATES BETWEEN 2011-2021
Mar 18, 2026, 21:38 PM -
POLYGENIC RISK SCORES IMPROVE NON-SMALL CELL LUNG CANCER PREDICTION IN REAL-WORLD US DATA
Mar 18, 2026, 21:38 PM
